22. European Stroke Conference 12:45-14:15 Room 2,3,4 Lunch Satellite Symposium Bayer Guidance and real-world experience with oral anticoagulation in atrial fibrilla-tion – what the neurologist needs to know Chairs: H.-C. Diener, Germany, and K. Fox, UK Welcome and introduction H.-C. Diener, Germany Anticoagulation and AF-related stroke – time for change K. Fox, UK New treatment options – from studies to clinical practice B. Norrving, Sweden Real-world patient management – what we currently know S. Haas, Germany Summary and close K. Fox, UK Industry sponsored lunch symposium by Bayer 12:45-14:15 E-Poster Session Red p. 220 and Poster Session Red p.276 14:30-16:30 Auditorium Educational Symposium 1 Management of hypertension in acute ICH Management of hypertension in acute ICH Chairs: C. Anderson, Australia and P. Bath, UK Therapeutic targets for the management of hypertension in acute ICH P. Bath, UK Which patients with ICH are likely to benefit most from rapid blood pressure lowering? E. Heeley, Australia What is the relationship between effects of timing and degree of blood pressure control on haematoma volumes and outcomes? C. Stapf, France Further updates on the INTERACT 2 results C. Anderson, Australia Implications for clinical practice J. Saver, USA 36 © 2013 S. Karger AG, Basel Scientific Programme
Karger_ESC London_2013
To see the actual publication please follow the link above